| Rus |  |
Eng |  |
Materials Research Centre developes two-stage technology for calcination of petroleum coke, which includes the first stage of heating of coke to a temperature of 900-1200 ° C in order to remove the bulk of the volatile products and to ensure consistent quality of coke and second stage high-temperature processing in coke furnace with an electrothermal fluidized layer at a temperature of 2000-2500 ° C.
As a result of high-temperature treatment the content of harmful impurities provide an opportunity to obtain high carbon product that can be used in metallurgy, and chemical production.
Results of additional testings, obtained by MRC, showed that the most promising is to use calcinated coke as raw material. It has a reduced electrical resistance, to realize the process of heating by direct passing a current through a layer of material that can provide recycling of the heat of the finished product. This reduces the cleaning gases, as well as the possibility of a significant increase the processing temperature of coke.
Before the manufacturing of the furnace were provided analitical calculations, stress and thermal analysis, optimization of the equipment parts or process, CAD design and 3d visualization.
3D visualization of the c with additional units (screw feeder, loading bin) and special welding assembly device
Manufacturing of the furnace, its technological parts
Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.